Middle East & Africa Pediatric Cardiology Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The Middle East & Africa pediatric cardiology market size is expected to reach US$ 283.16 million by 2031 from US$ 200.65 million in 2024. The market is estimated to record a CAGR of 5.0% from 2024 to 2031.

Executive Summary and Middle East & Africa Pediatric Cardiology Market Analysis:

The pediatric cardiology market in the Middle East & Africa is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The market in this region is driven by factors such as the modernization of healthcare infrastructure and increasing awareness of heart diseases among children. Furthermore, government initiatives are playing a pivotal role in developing pediatric cardiology solutions, which is expected to accelerate market growth in the coming years.

Middle East & Africa Pediatric Cardiology Market: Strategic Insights

Middle East & Africa Pediatric Cardiology Market Segmentation Analysis:

Key segments that contributed to the derivation of the Middle East & Africa pediatric cardiology market analysis are product type, disease indication, surgical procedure, and end user.

• Based on product type, the Middle East & Africa pediatric cardiology market is segmented into transcatheter heart valves, occlusion devices, catheters, stents, introducer sheaths, and others. The transcatheter heart valves segment held the largest share of the market in 2024.

• By disease indication, the Middle East & Africa pediatric cardiology market is segmented into congenital heart disease, acquired heart disease, arrhythmias, cardiomyopathies, and others. The congenital heart disease segment held the largest share of the market in 2024.

• By surgical procedure, the Middle East & Africa pediatric cardiology market is segmented into interventional procedures, heart rhythm management procedures, and others. The interventional procedures segment held the largest share of the market in 2024.

• Based on end user, the Middle East & Africa pediatric cardiology market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the market in 2024.

Middle East & Africa Pediatric Cardiology Market Players Density: Understanding Its Impact on Business Dynamics

The Middle East & Africa Pediatric Cardiology Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Middle East & Africa Pediatric Cardiology Market Outlook

Chronic congenital heart disease (CCHD), tetralogy of Fallot, ventricular septal defect, and atrial septal defect are a few congenital heart diseases (CHDs) that are present from birth. The rising prevalence of maternal health issues, such as diabetes and obesity, has been linked to an increased risk of CHD in newborns. According to the Children's Heartlink organization 2024 report, ~1.3 million children are born with CHD globally every year. As survival rates for infants with CHD improve due to advancements in medical care, there is a growing population of children and adolescents requiring ongoing cardiology services. This shift has resulted in a heightened demand for specialized pediatric cardiac care, including diagnostic, surgical, and therapeutic interventions. Thus, the increasing incidence of various congenital heart diseases (CHDs) in the pediatric population fuels the growth of the global pediatric cardiology market.

Middle East & Africa Pediatric Cardiology Market Country Insights

Based on country, the Middle East & Africa pediatric cardiology market comprises Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. South Africa held the largest share in 2024.

South Africa is one of the major economies in the Middle East & Africa; the country recorded a GDP of US$ 377.78 billion in 2023, and healthcare accounted for the second-largest share of the overall GDP (~8.5%). Increased healthcare funding enables the development of dedicated heart centers and improved diagnostic tools, subsequently enabling the expansion of pediatric cardiology services. As healthcare spending rises, the public and private sectors can invest in training more pediatric cardiologists to meet the growing demand for specialized care. In South Africa, heart disease in children is a significant concern, with CHD being one of the most common birth defects. According to Children's HeartLink's Africa Children's Hearts Initiative, CHD is currently the 7th leading cause of infant mortality in Africa, accounting for 34,000 preventable deaths annually. Each year, an estimated 500,000 children are born with CHD in the nation. Approximately 90% of these children lack access to the necessary medical care and treatment to manage the condition effectively. The rising awareness and need for specialized pediatric cardiology services are evident in both urban and rural areas.

The market is bolstered by the presence of organizations aimed at increasing treatment access and partnerships with organizations such as the Children's Heart Foundation contributing to capacity-building in South Africa by offering training programs for healthcare professionals. Similarly, the Children's Cardiac Foundation of Africa is dedicated to saving lives and enhancing the health of children with CHD across Africa. The foundation achieves this by raising funds to facilitate heart surgeries and providing training for specialists and support staff in pediatric cardiac care.

Middle East & Africa Pediatric Cardiology Market Company Profiles

Some of the key players operating in the market include Abbott Laboratories, Medtronic Plc, Edwards Lifesciences Corp, Terumo Corp, W L Gore & Associates Inc, NuMED, Cordis Corp, Occlutech US LLC, Biotronik SE & Co KG, and RENATA MEDICAL, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa Pediatric Cardiology Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.

• Industry trade journals and other relevant publications.

• Government documents, statistical databases, and market reports.

• News articles, press releases, and webcasts specific to companies operating in the market.

Note:

All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.

• Enhance the expertise and market understanding of the analysis team.

• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers

• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise